Back to Search
Start Over
A Phase II Trial of Docetaxel With Bevacizumab as First-line Therapy for HER2-Negative Metastatic Breast Cancer (TORI B01)
- Source :
- Clinical Breast Cancer; Aug2010, Vol. 10 Issue 4, p307-312, 6p
- Publication Year :
- 2010
Details
- Language :
- English
- ISSN :
- 15268209
- Volume :
- 10
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Clinical Breast Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 104915554
- Full Text :
- https://doi.org/10.3816/CBC.2010.n.040